Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  trimethoprim-sulfamethoxazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065093, U10CA037420, URCC-U10994, NCI-C95-0001, URCC-URRSRB-6993, NCI-P96-0073, ECOG-U1099, C95-0001, NCT00002850
Phase III Empirical Antimicrobial Therapy vs Early Open Lung Biopsy/Specific Therapy for Diffuse Interstitial Pneumonitis in Immunocompromised Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-111
Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-81-C-189, NCI-POB-8103
Phase III Comparison of ARA-C/DNM/TG vs ARA-C/VCR/DM for Remission Induction plus Intensive Multi-Drug Maintenance for Previously Untreated Pediatric ANLL
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8101, POG-ANLL-2
Phase III Pilot Chemotherapy with Short-Course ProMACE-CytaBOM (CTX/ADR/VP-16/ARA-C/BLEO/VCR/MTX/PRED) for the Treatment of Patients with Stages II-IV Diffuse Aggressive Lymphomas
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: CRB-8807E, NCI-87-C-180C, NCI-T87-0307N, T87-0307
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: DM93-058, P30CA016672, MDA-DM-93058, NCI-T93-0088D, CDR0000078316, T93-0088, NCT00002524
SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000063620, SWOG-9320, U10CA032102, NCT00002571
Phase I Pilot Study of ZDV in HIV-Seropositive Patients Undergoing Allogeneic Bone Marrow Transplantation for non-Hodgkin's Lymphoma (Summary Last Modified 03/95)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor:
Protocol IDs: FHCRC-526.0, NCI-V94-0412
Comparison of Oral Antibiotic Combinations to Prevent Infections in Relapsed Leukemic Patients and in Oat Cell Carcinoma Patients
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7714
Intensive Combination Chemotherapy with ACE (ADR/CTX/VP-16) vs ACE-II (ADR/CTX/HD Infusion VP-16) for Small Cell Carcinoma of the Lung
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8020
Prospective, Randomized Evaluation of Trimethoprim-Sulfamethoxazole in the Prevention of Early Infection in Multiple Myeloma (Summary Last Modified 07/90)
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: URCC-2481M, NCI-T83-1397D, T83-1397
Start Over